ArticleChild and adolescent psychiatry and mental health2010
Controversies concerning the diagnosis and treatment of bipolar disorder in children.
Article in Child and adolescent psychiatry and mental health, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.Bipolar disorders · 2018Guideline
- Atypical antipsychotics for disruptive behaviour disorders in children and youths.The Cochrane database of systematic reviews · 2017Pooled it
- The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School.Journal of child and adolescent psychopharmacology · 2016Trial
- Brain structural-functional connectivity coupling and glucose metabolism in adolescents with bipolar disorder and major depressive disorder.European journal of nuclear medicine and molecular imaging · 2026Article
- The DADYS-Screen: Development and Evaluation of a Screening Tool for Affective Dysregulation in Children.Assessment · 2023Article
- Barriers to timely identification of bipolar disorder in youth: a multidimensional perspective.Frontiers in child and adolescent psychiatry · 2023Article
- Is the 4-factor model of symptomology equivalent across bipolar disorder subtypes?International journal of bipolar disorders · 2021Article
- The Globalization of Biological Psychiatry and the Rise of Bipolar Spectrum Disorder in Iran.Culture, medicine and psychiatry · 2020Article
- The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: Knowledge to date and directions for future research.Bipolar disorders · 2017Review
- Disruptive Mood Dysregulation Disorder in a Community Mental Health Clinic: Prevalence, Comorbidity and Correlates.Journal of child and adolescent psychopharmacology · 2016Article
- An empirically based alternative to DSM-5's disruptive mood dysregulation disorder for ICD-11.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2015Article
- Psychiatric disorders in adolescents and young adults with Down syndrome and other intellectual disabilities.Journal of neurodevelopmental disorders · 2015Article
- Pediatric Bipolar Disorder: Subtype Trend and Impact of Behavioral Comorbidities.Journal of clinical medicine · 2014Article
- Diagnostic profiles and clinical characteristics of youth referred to a pediatric mood disorders clinic.Journal of psychiatric practice · 2014Article
- First Manic Episode in an 11 Year-old Girl.Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent · 2013Article
- Frontostriatal neuroimaging findings differ in patients with bipolar disorder who have or do not have ADHD comorbidity.Journal of affective disorders · 2013Article
- Pediatric bipolar disorder in an era of "mindless psychiatry".Journal of trauma & dissociation : the official journal of the International Society for the Study of Dissociation (ISSD) · 2012Review
- Do we really know how to treat a child with bipolar disorder or one with severe mood dysregulation? Is there a magic bullet?Depression research and treatment · 2012Article
- Broadening the diagnosis of bipolar disorder: benefits vs. risks.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2011Article
- Treatment of Pediatric Bipolar Disorder: A Review.Minerva psichiatrica · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This commentary grows out of an interdisciplinary workshop focused on controversies surrounding the diagnosis and treatment of bipolar disorder (BP) in children. Although debate about the occurrence and frequency of BP in children is more than 50 years old, it increased in the mid 1990s when researchers adapted the DSM account of bipolar symptoms to diagnose children. We offer a brief history of the debate from the mid 90s through the present, ending with current efforts to distinguish between a small number of children whose behaviors closely fit DSM criteria for BP, and a significantly larger number of children who have been receiving a BP diagnosis but whose behaviors do not closely fit those criteria. We agree with one emerging approach, which gives part or all of that larger number of children a new diagnosis called Severe Mood Dysregulation or Temper Dysregulation Disorder with Dysphoria.Three major concerns arose about interpreting the DSM criteria more loosely in children than in adults. If clinicians offer a treatment for disorder A, but the patient has disorder B, treatment may be compromised. Because DSM's diagnostic labels are meant to facilitate research, when they are applied inconsistently, such research is compromised. And because BP has a strong genetic component, the label can distract attention from the family or social context.Once a BP diagnosis is made, concerns remain regarding the primary, pharmacological mode of treatment: data supporting the efficacy of the often complex regimens are weak and side effects can be significant. However, more than is widely appreciated, data do support the efficacy of the psychosocial treatments that should accompany pharmacotherapy. Physicians, educators, and families should adopt a multimodal approach, which focuses as much on the child's context as on her body. If physicians are to fulfill their ethical obligation to facilitate truly informed consent, they must be forthcoming with families about the relevant uncertainties and complexities.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.